Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C9DC
|
|||
Former ID |
DNC004983
|
|||
Drug Name |
SK&F-64139
|
|||
Synonyms |
SK-64139
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H9Cl2N
|
|||
Canonical SMILES |
C1CNCC2=C1C=CC(=C2Cl)Cl
|
|||
InChI |
1S/C9H9Cl2N/c10-8-2-1-6-3-4-12-5-7(6)9(8)11/h1-2,12H,3-5H2
|
|||
InChIKey |
WFPUBEDBBOGGIQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 61563-24-4
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:160129
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor alpha-2A (ADRA2A) | Target Info | Inhibitor | [1] |
Adrenergic receptor alpha-2B (ADRA2B) | Target Info | Inhibitor | [1] | |
Adrenergic receptor alpha-2C (ADRA2C) | Target Info | Inhibitor | [1] | |
KEGG Pathway | cGMP-PKG signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Panther Pathway | Alpha adrenergic receptor signaling pathway | |||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Reactome | Adrenoceptors | |||
Adrenaline signalling through Alpha-2 adrenergic receptor | ||||
G alpha (i) signalling events | ||||
G alpha (z) signalling events | ||||
Adrenaline,noradrenaline inhibits insulin secretion | ||||
Surfactant metabolism | ||||
WikiPathways | Monoamine GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
Platelet Aggregation (Plug Formation) | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Integration of energy metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phen... J Med Chem. 2006 Sep 7;49(18):5424-33. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.